Smith & Nephew SNATS PE Ratio 2010-2023 | SNN
Current and historical p/e ratio for Smith & Nephew SNATS (SNN) from 2010 to 2023. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Smith & Nephew SNATS PE ratio as of April 24, 2024 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
Smith & Nephew SNATS PE Ratio Historical Data | |||
---|---|---|---|
Date | Stock Price | TTM Net EPS | PE Ratio |
2024-04-24 | 24.57 | inf | |
2019-12-31 | 42.82 | 0 | 0.00 |
2019-06-30 | 38.55 | 0 | 0.00 |
2018-12-31 | 32.73 | 0 | 0.00 |
2018-06-30 | 32.61 | 0 | 0.00 |
2017-12-31 | 30.06 | 0 | 0.00 |
2017-06-30 | 29.72 | 0 | 0.00 |
2016-12-31 | 25.35 | $0.36 | 70.41 |
2015-12-31 | 29.44 | $0.59 | 49.90 |
2015-06-30 | 27.89 | $0.59 | 47.27 |
2014-12-31 | 29.86 | $0.79 | 37.79 |
2014-09-30 | 27.18 | $0.77 | 35.48 |
2022-12-31 | 25.64 | $0.90 | 28.62 |
2014-06-30 | 28.82 | $1.16 | 24.76 |
2014-03-31 | 24.40 | $1.25 | 19.55 |
2013-12-31 | 22.89 | $1.23 | 18.64 |
2013-09-30 | 19.75 | $1.18 | 16.68 |
2013-06-30 | 17.75 | $0.92 | 19.38 |
2013-03-31 | 18.01 | $0.93 | 19.33 |
2012-12-31 | 17.28 | $1.27 | 13.59 |
2022-06-30 | 26.29 | $1.32 | 19.98 |
2012-09-30 | 17.03 | $1.63 | 10.46 |
2012-06-30 | 15.45 | $1.63 | 9.49 |
2012-03-31 | 15.44 | $1.31 | 11.77 |
2011-12-31 | 14.72 | $1.30 | 11.33 |
2011-09-30 | 13.57 | $0.99 | 13.74 |
2011-06-30 | 16.45 | $1.10 | 15.01 |
2011-03-31 | 16.99 | $1.06 | 16.09 |
2021-12-31 | 32.14 | $1.02 | 31.63 |
2010-12-31 | 15.82 | $1.38 | 11.50 |
2010-09-30 | 13.58 | $1.26 | 10.81 |
2010-06-30 | 14.06 | $1.24 | 11.30 |
2010-03-31 | 14.85 | $1.20 | 12.34 |
2009-12-31 | 15.21 | $0.84 | 18.02 |
2009-09-30 | 13.28 | $0.78 | 17.11 |
2009-06-30 | 10.99 | $0.49 | 22.51 |
2021-06-30 | 39.99 | $0.22 | 181.76 |
2009-03-31 | 9.11 | $0.22 | 41.40 |
2020-12-31 | 38.35 | 0 | 0.00 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $10.741B | $5.549B |
Smith & Nephew is a global medical device company. The company markets clinically superior products, principally in orthopaedics, endoscopy and wound management to deliver cost-effective solutions, significant physicianadvantage and real patient benefits. A continuous process of supplying new and innovative products is supported by substantial R&D investment todeliver new levels of healing to patients throughout the world |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $185.474B | 24.35 |
Stryker (SYK) | United States | $128.161B | 31.78 |
Boston Scientific (BSX) | United States | $106.966B | 34.07 |
Medtronic (MDT) | Ireland | $106.730B | 15.11 |
EssilorLuxottica (ESLOY) | France | $99.574B | 0.00 |
Lonza Group Ag (LZAGY) | Switzerland | $42.648B | 0.00 |
Haleon (HLN) | United Kingdom | $38.127B | 29.82 |
ResMed (RMD) | United States | $27.032B | 27.03 |
Terumo (TRUMY) | Japan | $25.476B | 35.98 |
Zimmer Biomet Holdings (ZBH) | United States | $24.896B | 16.03 |
Baxter (BAX) | United States | $20.785B | 15.16 |
Koninklijke Philips (PHG) | Netherlands | $19.474B | 15.53 |
Insulet (PODD) | United States | $11.711B | 61.49 |
Demant (WILYY) | Denmark | $9.943B | 0.00 |
Bio-Rad Laboratories (BIO) | United States | $7.934B | 23.64 |
BellRing Brands (BRBR) | United States | $7.285B | 39.17 |
Lantheus Holdings (LNTH) | United States | $4.470B | 11.54 |
Haemonetics (HAE) | United States | $4.379B | 22.40 |
Perrigo (PRGO) | Ireland | $4.232B | 12.10 |
GN Store Nord (GNNDY) | Denmark | $3.937B | 25.50 |
Envista Holdings (NVST) | United States | $3.485B | 13.26 |
Prestige Consumer Healthcare (PBH) | United States | $3.482B | 16.46 |
QuidelOrtho (QDEL) | United States | $2.730B | 9.91 |
Neogen (NEOG) | United States | $2.679B | 25.77 |
Green Thumb Industries (GTBIF) | United States | $2.630B | 83.33 |
ICU Medical (ICUI) | United States | $2.357B | 17.58 |
TG Therapeutics (TGTX) | United States | $2.161B | 699.00 |
Maravai LifeSciences Holdings (MRVI) | United States | $1.928B | 0.00 |
Owens & Minor (OMI) | United States | $1.895B | 18.19 |
Verano Holdings (VRNOF) | United States | $1.790B | 0.00 |
Agios Pharmaceuticals (AGIO) | United States | $1.780B | 0.00 |
InMode (INMD) | Israel | $1.458B | 7.55 |
LeMaitre Vascular (LMAT) | United States | $1.437B | 47.43 |
National Vision Holdings (EYE) | United States | $1.388B | 43.24 |
AdaptHealth (AHCO) | United States | $1.300B | 9.78 |
Warby Parker (WRBY) | United States | $1.287B | 0.00 |
AtriCure (ATRC) | United States | $1.115B | 0.00 |
MacroGenics (MGNX) | United States | $0.982B | 0.00 |
Canopy Growth (CGC) | Canada | $0.899B | 0.00 |
BioLife Solutions (BLFS) | United States | $0.779B | 0.00 |
Cresco Labs (CRLBF) | United States | $0.712B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.693B | 14.98 |
Evolus (EOLS) | United States | $0.666B | 0.00 |
Quanterix (QTRX) | United States | $0.613B | 0.00 |
Jin Medical (ZJYL) | China | $0.547B | 0.00 |
Valneva SE (VALN) | France | $0.540B | 0.00 |
Phibro Animal Health (PAHC) | United States | $0.509B | 11.02 |
PetIQ (PETQ) | United States | $0.487B | 18.17 |
TerrAscend (TSNDF) | Canada | $0.478B | 0.00 |
ZimVie (ZIMV) | United States | $0.430B | 26.35 |
OraSure Technologies (OSUR) | United States | $0.421B | 6.96 |
Biote (BTMD) | United States | $0.417B | 3.96 |
Aurora Cannabis (ACB) | Canada | $0.393B | 0.00 |
Surmodics (SRDX) | United States | $0.371B | 40.11 |
Zynex (ZYXI) | United States | $0.361B | 41.59 |
Viemed Healthcare (VMD) | United States | $0.314B | 31.11 |
Cerus (CERS) | United States | $0.301B | 0.00 |
Sanara MedTech (SMTI) | United States | $0.280B | 0.00 |
TriSalus Life Sciences (TLSI) | United States | $0.274B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.241B | 14.70 |
Organigram Holdings (OGI) | Canada | $0.199B | 0.00 |
Veru (VERU) | United States | $0.193B | 0.00 |
Ayr Wellness (AYRWF) | United States | $0.192B | 0.00 |
Omeros (OMER) | United States | $0.176B | 0.00 |
Quipt Home Medical (QIPT) | United States | $0.163B | 0.00 |
High Tide (HITI) | Canada | $0.160B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.159B | 0.00 |
Jushi Holdings (JUSHF) | United States | $0.134B | 0.00 |
Eagleford Energy (GRUSF) | United States | $0.130B | 65.20 |
FitLife Brands (FTLF) | United States | $0.129B | 20.74 |
InterCure (INCR) | Israel | $0.122B | 20.54 |
Fonar (FONR) | United States | $0.102B | 8.80 |
Cellectar Biosciences (CLRB) | United States | $0.099B | 0.00 |
MariMed (MRMD) | United States | $0.097B | 0.00 |
Oramed Pharmaceuticals (ORMP) | United States | $0.096B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.088B | 0.00 |
Brainsway (BWAY) | Israel | $0.084B | 0.00 |
Safety Shot (SHOT) | United States | $0.081B | 0.00 |
Chimerix (CMRX) | United States | $0.081B | 0.00 |
Zevia PBC (ZVIA) | United States | $0.060B | 0.00 |
Eagle Pharmaceuticals (EGRX) | United States | $0.059B | 3.86 |
Apyx Medical (APYX) | United States | $0.052B | 0.00 |
Cytosorbents (CTSO) | United States | $0.045B | 0.00 |
Rockwell Medical (RMTI) | United States | $0.044B | 0.00 |
ImmuCell (ICCC) | United States | $0.039B | 0.00 |
United-Guardian (UG) | United States | $0.039B | 15.04 |
Bright Green (BGXX) | United States | $0.037B | 0.00 |
Modular Medical (MODD) | United States | $0.035B | 0.00 |
Exagen (XGN) | United States | $0.024B | 0.00 |
Nephros (NEPH) | United States | $0.023B | 0.00 |
Flora Growth (FLGC) | United States | $0.020B | 0.00 |
Agape ATP (ATPC) | $0.020B | 0.00 | |
FSD PHARMA (HUGE) | Canada | $0.018B | 0.00 |
Meihua Medical Technologies (MHUA) | China | $0.017B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
GlucoTrack (GCTK) | United States | $0.013B | 0.00 |
GUARDION HEALTH (GHSI) | United States | $0.010B | 72.54 |
NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
Sharps Technology (STSS) | United States | $0.005B | 0.00 |
Senestech (SNES) | United States | $0.004B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.003B | 0.00 |
Lucy Scientific Discovery (LSDI) | Canada | $0.002B | 0.00 |
Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
Smart For Life (SMFL) | United States | $0.001B | 0.00 |
Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
SNDL (SNDL) | Canada | $0.000B | 0.00 |